About
Xtl Biopharmaceuticals Ltd (TA:XTLB) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 20 2026
XTL Biopharmaceuticals Announces ADS Ratio Change
Feb 27 2026
XTL Announces Receipt of Staff Delist Determination from Nasdaq and Plans to Request Hearing
Jan 29 2026
XTL Update on Recent Developments
Jan 23 2026
XTL Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders’ Equity Deficiency
Jan 13 2026
XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership